INHIBITORS OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA FORMATION AND THEIR METHOD OF USE
摘要
Pharmaceutical compositions of the invention comprise covalently closed circular DNA formation inhibitors having a disease-modifying action in the treatment of diseases associated with the formation of covalently closed circular DNA that include hepatitis B infection, and any disease involving formation of covalently closed circular DNA.
申请公布号
WO2013130703(A3)
申请公布日期
2015.03.12
申请号
WO2013US28150
申请日期
2013.02.28
申请人
BARUCH S. BLUMBERG INSTITUTE;PHILADELPHIA HEALTH & EDUCATION CORPORATION D/B/ADREXEL UNIVERSITY COLLEGE OF MEDICINE
